Thomas Wechsler

1.4k total citations
29 papers, 1.1k citations indexed

About

Thomas Wechsler is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Thomas Wechsler has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Genetics and 9 papers in Physiology. Recurrent topics in Thomas Wechsler's work include CRISPR and Genetic Engineering (12 papers), Virus-based gene therapy research (10 papers) and Lysosomal Storage Disorders Research (9 papers). Thomas Wechsler is often cited by papers focused on CRISPR and Genetic Engineering (12 papers), Virus-based gene therapy research (10 papers) and Lysosomal Storage Disorders Research (9 papers). Thomas Wechsler collaborates with scholars based in United States, Switzerland and United Kingdom. Thomas Wechsler's co-authors include Stephen C. West, Scott Newman, Scott Sproul, Michael C. Holmes, H. Zuber, Franz Suter, Russell C. DeKelver, R. Clinton Fuller, David E. Paschon and Shangzhen Zhou and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Thomas Wechsler

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Wechsler United States	13	878	285	200	179	127	29	1.1k
Danilo Ritz Switzerland	19	871 1.0×	85 0.3×	229 1.1×	145 0.8×	383 3.0×	40	1.3k
Mary Ann Price United States	20	1.3k 1.5×	497 1.7×	355 1.8×	55 0.3×	161 1.3×	24	2.0k
Cindy Y. Jao United States	11	1.4k 1.6×	269 0.9×	124 0.6×	42 0.2×	152 1.2×	11	1.7k
Yaron Daniely United States	10	951 1.1×	154 0.5×	298 1.5×	43 0.2×	70 0.6×	16	1.3k
Jean‐Baptiste Vannier United Kingdom	13	1.5k 1.7×	160 0.6×	287 1.4×	511 2.9×	97 0.8×	16	1.7k
Alexander K. Haas Germany	15	1.1k 1.3×	282 1.0×	96 0.5×	148 0.8×	965 7.6×	23	1.7k
Rebecca Andrews United States	13	365 0.4×	223 0.8×	168 0.8×	39 0.2×	124 1.0×	24	872
Paolo Swuec Italy	15	759 0.9×	95 0.3×	74 0.4×	102 0.6×	56 0.4×	24	857
Stéphane Koundrioukoff France	18	1.5k 1.7×	301 1.1×	388 1.9×	66 0.4×	315 2.5×	24	1.7k
Sebastian Iben Germany	16	1.1k 1.3×	163 0.6×	93 0.5×	74 0.4×	169 1.3×	35	1.3k

Countries citing papers authored by Thomas Wechsler

Since Specialization

Citations

This map shows the geographic impact of Thomas Wechsler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wechsler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wechsler more than expected).

Fields of papers citing papers by Thomas Wechsler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wechsler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wechsler. The network helps show where Thomas Wechsler may publish in the future.

Co-authorship network of co-authors of Thomas Wechsler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wechsler. A scholar is included among the top collaborators of Thomas Wechsler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wechsler. Thomas Wechsler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Lei, Selina S. Dwight, Brendan J. Beahm, et al.. (2022). AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 Deficiency. Molecular Therapy — Methods & Clinical Development. 27. 259–271. 12 indexed citations

Pagant, Silvère, Luciana Moreira, Lin Gan, et al.. (2021). ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice. Molecular Therapy. 29(11). 3230–3242. 13 indexed citations

Mueller, William F., Lei Zhu, Selina S. Dwight, et al.. (2021). GlcNAc-Asn is a biomarker for NGLY1 deficiency. The Journal of Biochemistry. 171(2). 177–186. 17 indexed citations

Yasuda, Makiko, Silvère Pagant, Lin Gan, et al.. (2020). AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction. Molecular Therapy — Methods & Clinical Development. 18. 607–619. 41 indexed citations

Ou, Li, Russell C. DeKelver, Michelle Rohde, et al.. (2018). ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome. Molecular Therapy. 27(1). 178–187. 64 indexed citations

Laoharawee, Kanut, Russell C. DeKelver, Kelly M. Podetz-Pedersen, et al.. (2018). Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing. Molecular Therapy. 26(4). 1127–1136. 91 indexed citations

Harmatz, Paul, Joseph Muenzer, Barbara K. Burton, et al.. (2018). Update on phase 1/2 clinical trials for MPS I and MPS II using ZFN-mediated in vivo genome editing. Molecular Genetics and Metabolism. 123(2). S59–S60. 9 indexed citations

DeKelver, Russell C., Li Ou, Kanut Laoharawee, et al.. (2017). ZFN-mediated in vivo genome editing results in phenotypic correction in murine MPS I and MPS II models. Molecular Genetics and Metabolism. 120(1-2). S41–S41. 1 indexed citations

Ou, Li, Russell C. DeKelver, Susan Tom, et al.. (2016). ZFN-mediated correction of murine MPS I model by expression of the human IDUA cDNA from the albumin “safe harbor” locus. Molecular Genetics and Metabolism. 117(2). S89–S89. 1 indexed citations

10.

Ou, Li, Russell C. DeKelver, Susan Tom, et al.. (2016). 485. ZFN-Mediated Liver-Targeting Gene Therapy Corrects Systemic and Neurological Disease of Mucopolysaccharidosis Type I. Molecular Therapy. 24. S192–S193. 1 indexed citations

11.

Wechsler, Thomas, Kathleen Meyer, S. Kaye Spratt, et al.. (2015). ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates. Blood. 126(23). 200–200. 3 indexed citations

12.

DeKelver, Russell C., Michelle Rohde, Susan Tom, et al.. (2015). ZFN-mediated genome editing of albumin “safe harbor” in vivo results in supraphysiological levels of human IDS, IDUA and GBA in mice. Molecular Genetics and Metabolism. 114(2). S36–S36. 3 indexed citations

13.

Wechsler, Thomas, Michelle Rohde, Susan Tom, et al.. (2015). 479. ZFN-Mediated In Vivo Genome Editing Results in Supraphysiological Levels of Lysosomal Enzymes Deficient in Hunter and Hurler Syndrome and Gaucher Disease. Molecular Therapy. 23. S190–S190. 2 indexed citations

14.

Sharma, Rajiv P., Xavier M. Anguela, Yannick Doyon, et al.. (2015). In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood. 126(15). 1777–1784. 235 indexed citations

15.

Anguela, Xavier M., Rajiv P. Sharma, Yannick Doyon, et al.. (2013). ZFN Mediated Targeting Of Albumin “Safe Harbor” Results In Therapeutic Levels Of Human Factor VIII In a Mouse Model Of Hemophilia A. Blood. 122(21). 720–720. 2 indexed citations

16.

Wechsler, Thomas, Scott Newman, & Stephen C. West. (2011). Aberrant chromosome morphology in human cells defective for Holliday junction resolution. Nature. 471(7340). 642–646. 171 indexed citations

17.

Wechsler, Thomas, Benjamin P.C. Chen, Keiko Morotomi‐Yano, et al.. (2004). DNA–PKcs function regulated specifically by protein phosphatase 5. Proceedings of the National Academy of Sciences. 101(5). 1247–1252. 112 indexed citations

18.

Wechsler, Thomas, René Brunisholz, Gerhard Frank, & H. Zuber. (1991). Isolation and protein chemical characterization of the B806-866 antenna complex of the green thermophilic bacterium Chloroflexus aurantiacus. Journal of Photochemistry and Photobiology B Biology. 8(2). 189–197. 8 indexed citations

19.

Wechsler, Thomas, Franz Suter, R. Clinton Fuller, & H. Zuber. (1985). The complete amino acid sequence of the bacteriochlorophyll c binding polypeptide from chlorosomes of the green photosynthetic bacterium Chloroflexus aurantiacus. FEBS Letters. 181(1). 173–178. 62 indexed citations

20.

Wechsler, Thomas, René Brunisholz, Franz Suter, R. Clinton Fuller, & H. Zuber. (1985). The complete amino acid sequence of a bacteriochlorophyll a binding polypeptide isolated from the cytoplasmic membrane of the green photosynthetic bacterium Chloroflexus aurantiacus. FEBS Letters. 191(1). 34–38. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact